This report is the product of an almost year-long inquiry into the availability and affordability of drugs and diagnostics across the developing world. According to the All-Party Parliamentary Group on HIV and AIDS, despite notable success in the global AIDS response, access to medicines is threatened by withdrawal of funding in middle-income countries, the imposition of ever stricter rules on intellectual property, a failure to reach key population groups like LGBT people, sex workers and people who inject drugs, and insufficient R&D for child-friendly anti-retrovirals and treatments for HIV co-infections like TB.
Access Denied report calls for:
- Review of funding decisions affecting middle income countries
- Global Fund leadership on Hepatitis C treatment
- Action to support use of TRIPS flexibilities to overcome high medicine prices
- Review of patent-based R&D model